Zhai You, Shang Hongcai, Li Yan, Zhang Nan, Zhang Jisi, Wu Shangwen
Henan University of Chinese Medicine, Zhengzhou, Henan, China.
Key Laboratory of Chinese Internal Medicine of Ministry of Education and Beijing, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.
Front Physiol. 2025 Apr 9;16:1514585. doi: 10.3389/fphys.2025.1514585. eCollection 2025.
This study aims to systematically review the risk factors for major adverse cardiovascular events (MACE) in patients with coronary heart disease who have undergone percutaneous coronary intervention (PCI).
Systematic review and meta-analysis.
The Cochrane Library, PubMed, Web of Science, China National Knowledge Infrastructure (CNKI), Wanfang Database, and VIP Database for Chinese Technical Periodicals (VIP) were screened until December 2024.
Case-control studies or cohort studies on the risk factors for MACE in patients with coronary heart disease who underwent PCI. Data extraction and synthesis: The literature review, data extraction, and quality evaluation were conducted by two independent researchers, and the meta-analysis was performed using RevMan 5.4 software.
The main outcome was that MACE occurred during the follow-up period.
A total of 40 articles were included. The meta-analysis erevealed that dyslipidemia (OR = 1.50; 95% CI [1.19, 1.89], = 0.0007), diabetes mellitus (OR = 1.70; 95% CI [1.43, 2.02], < 0.00001), hypertension (OR = 1.62; 95% CI [1.35, 1.96], < 0.0001), history of smoking (OR = 2.08; 95% CI [1.51, 2.85], < 0.0001), poorer ventricular function (OR = 2.39; 95% CI [2.17-2.64], < 0.0001), impaired left ventricular ejection fraction (LVEF) (OR = 1.86; 95% CI [1.71-2.03], < 0.0001), door to balloon (D-to-B) time (OR = 0.61; 95% CI [0.42-0.88]; = 0.009), thrombolysis in myocardial infarction (TIMI) (OR = 1.41; 95% CI [1.17, 1.70], = 0.0004), renal dysfunction (OR = 1.82; 95% CI [1.37, 2.43], < 0.0001), and multi-vessel coronary artery disease (OR = 0.41; 95% CI [0.37, 0.46], < 0.0001) were significantly associated with MACE after PCI.
The independent risk factors of MACE after PCI are dyslipidemia, hypertension, diabetes mellitus, smoking history, Killip class > II, LVEF ≤40%, D-to-B time >90 min, TIMI flow grade ≤ II, renal insufficiency, and multivessel disease.
本研究旨在系统评价接受经皮冠状动脉介入治疗(PCI)的冠心病患者发生主要不良心血管事件(MACE)的危险因素。
系统评价和荟萃分析。
检索Cochrane图书馆、PubMed、Web of Science、中国知网(CNKI)、万方数据库和维普中文科技期刊数据库(VIP),检索截至2024年12月的文献。
关于接受PCI的冠心病患者发生MACE危险因素的病例对照研究或队列研究。数据提取与合成:由两名独立研究人员进行文献回顾、数据提取和质量评估,并使用RevMan 5.4软件进行荟萃分析。
主要结局为随访期间发生MACE。
共纳入40篇文章。荟萃分析显示,血脂异常(比值比[OR]=1.50;95%置信区间[CI][1.19,1.89],P=0.0007)、糖尿病(OR=1.70;95%CI[1.43,2.02],P<0.00001)、高血压(OR=1.62;95%CI[1.35,1.96],P<0.0001)、吸烟史(OR=2.08;95%CI[1.51,2.85],P<0.0001)、心室功能较差(OR=2.39;95%CI[2.17-2.64],P<0.0001)、左心室射血分数(LVEF)受损(OR=1.86;95%CI[1.71-2.03],P<0.0001)、门球时间(D-to-B)(OR=0.61;95%CI[0.42-0.88];P=0.009)、心肌梗死溶栓(TIMI)(OR=1.41;95%CI[1.17,1.70],P=0.0004)、肾功能不全(OR=1.82;95%CI[1.37,2.43],P<0.0001)和多支冠状动脉疾病(OR=0.41;95%CI[0.37,0.46],P<0.0001)与PCI术后MACE显著相关。
PCI术后MACE的独立危险因素为血脂异常、高血压、糖尿病、吸烟史、Killip分级>Ⅱ级、LVEF≤40%、D-to-B时间>90分钟、TIMI血流分级≤Ⅱ级、肾功能不全和多支血管病变。